Welcome to LookChem.com Sign In|Join Free

CAS

  • or

640290-67-1

Post Buying Request

640290-67-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

640290-67-1 Usage

Uses

Neu2000, is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist.

Check Digit Verification of cas no

The CAS Registry Mumber 640290-67-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,0,2,9 and 0 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 640290-67:
(8*6)+(7*4)+(6*0)+(5*2)+(4*9)+(3*0)+(2*6)+(1*7)=141
141 % 10 = 1
So 640290-67-1 is a valid CAS Registry Number.

640290-67-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-hydroxy-TTBA

1.2 Other means of identification

Product number -
Other names 2-hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethylbenzylamino)benzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:640290-67-1 SDS

640290-67-1Relevant articles and documents

Concurrent Administration of Neu2000 and Lithium Produces Marked Improvement of Motor Neuron Survival, Motor Function, and Mortality in a Mouse Model of Amyotrophic Lateral Sclerosis

Shin, Jin Hee,Cho, Sung Ig,Lim, Hyang Ran,Lee, Jae Keun,Lee, Young Ae,Noh, Jai Sung,Joo, In Soo,Kim, Kee-Won,Gwag, Byoung Joo

, p. 965 - 975 (2007)

The Fas pathway and oxidative stress mediate neuronal death in stroke and may contribute to neurodegenerative disease. We tested the hypothesis that these two factors synergistically produce spinal motor neuron degeneration in amyotrophic lateral sclerosi

PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING BURN INJURIES

-

, (2012/03/08)

The present invention relates to a pharmaceutical composition and the method of use for treating or preventing burn injury in patients or subjects in need, including the compound represented by the specific chemical formula as an active ingredient or its pharmaceutically acceptable salts or solvates.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 640290-67-1